To The Moon

Shares of $Kala Pharmaceuticals Inc.$ shot up 16% in morning trading, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational new drug application for KPI-012, its treatment of persistent corneal epithelial defect .With the acceptance, the company said late Tuesday that it is now turning its focus to clinical execution, and is looking to initiate a Phase 2 trial KPI-012 in the first quarter of 2023.Also with the IND acceptance and under terms of a

Brighter days are likely coming, even if it feels hopeless today.

EV stocks jumped in morning trading. Xpeng rose over 17%; Nio rose over 15%; Tesla rose nearly 3%.

Company had too many people and warehouses after pandemic boomThird-party Amazon merchants are braci

Company’s mobile market share remains sliver of Apple, SamsungPixel 7 and Pixel 7 Pro focus on camer

Streaming media stocks dipped in morning trading. Disney, Netflix, Spotify, Roku and fuboTV fell bet

SummaryWhat does not kill you is likely to make you stronger.Selling puts gives you exposure while n

The warehouse club admits that it made some errors, but it has a plan to fix the issue that should d